Elicio Therapeutics, Inc. (ELTX) vs Grace Therapeutics, Inc. (GRCE)

A side-by-side comparison of Elicio Therapeutics, Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Elicio Therapeutics, Inc. logo
ELTX
Elicio Therapeutics, Inc.
$36M
$1.89HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Grace Therapeutics, Inc. logo
GRCE
Grace Therapeutics, Inc.
$34M
$2.12HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ELTX vs GRCE

growth of $100 · dividends reinvested · last 2y
ELTX -62.0% (-38.3%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
100200300Start $10020252026$38$68
ELTX GRCE

ELTX vs GRCE: by the numbers

  • •ELTX is the larger company ($36M vs $34M market cap).

Metrics side by side

Valuation

MetricELTXGRCE
P/B ratio4.540.71

Profitability

MetricELTXGRCE
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-476.77%-44.50%
ROIC-171.36%-52.61%

Go deeper

Full ELTX analysisFull GRCE analysisInteractive comparison tool

Dig into the metrics

Elicio Therapeutics ROEGrace Therapeutics ROEElicio Therapeutics operating marginGrace Therapeutics operating marginElicio Therapeutics revenue growthGrace Therapeutics revenue growthElicio Therapeutics free cash flowGrace Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.